Cargando…

Upregulated MUC2 Is an Unfavorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative CCRT

For locally advanced rectal cancer patients, introducing neoadjuvant concurrent chemoradiotherapy (CCRT) before radical resection allows tumor downstaging and increases the rate of anus retention. Since accurate staging before surgery and sensitivity prediction to CCRT remain challenging, a more pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chou, Chia-Lin, Chen, Tzu-Ju, Tian, Yu-Feng, Chan, Ti-Chun, Yeh, Cheng-Fa, Li, Wan-Shan, Tsai, Hsin-Hwa, Li, Chien-Feng, Lai, Hong-Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304358/ https://www.ncbi.nlm.nih.gov/pubmed/34300195 http://dx.doi.org/10.3390/jcm10143030

Ejemplares similares

CTSE Overexpression Is an Adverse Prognostic Factor for Survival among Rectal Cancer Patients Receiving CCRT
por: Chou, Chia-Lin, et al.
Publicado: (2021)

High SPINK4 Expression Predicts Poor Outcomes among Rectal Cancer Patients Receiving CCRT
por: Chen, Tzu-Ju, et al.
Publicado: (2021)

SYNPO2 upregulation is an unfavorable prognostic factor for nasopharyngeal carcinoma patients
por: Chang, Shih-Lun, et al.
Publicado: (2023)

Upregulated Ubiquitin D is a Favorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy
por: Chou, Chia-Lin, et al.
Publicado: (2022)

SERPINB5 Expression: Association with CCRT Response and Prognostic Value in Rectal Cancer
por: Chang, I-Wei, et al.
Publicado: (2018)

A Bayesian network meta-analysis of the primary definitive therapies for locoregionally advanced nasopharyngeal carcinoma: IC+CCRT, CCRT+AC, and CCRT alone
por: Zhang, Zhan-Jie, et al.
Publicado: (2022)

Comparative Clinical Efficacy of ‘Concurrent Chemoradiotherapy (CCRT) and Anlotinib’ Than CCRT in Patients with Locally Advanced ESCC
por: Wang, Gang, et al.
Publicado: (2022)

The CCRT: an inexpensive cosmic ray muon detector
por: Harpell, E, et al.
Publicado: (1995)

DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study
por: Tsai, Meng-Chen, et al.
Publicado: (2016)

High Stromal SFRP2 Expression in Urothelial Carcinoma Confers an Unfavorable Prognosis
por: Lai, Hong-Yue, et al.
Publicado: (2022)

Can CCRT/RT Achieve Favorable Oncologic Outcome in Rectal Cancer Patients With High Risk Feature After Local Excision?
por: Kim, Seijong, et al.
Publicado: (2022)

Texture Analysis as Imaging Biomarker for recurrence in advanced cervical cancer treated with CCRT
por: Meng, Jie, et al.
Publicado: (2018)

Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method
por: Chen, Xueling, et al.
Publicado: (2017)

Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer
por: Yu, Jing, et al.
Publicado: (2016)

DCE-MRI Perfusion and Permeability Parameters as predictors of tumor response to CCRT in Patients with locally advanced NSCLC
por: Tao, Xiuli, et al.
Publicado: (2016)

Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients
por: Chen, Tzu-Ju, et al.
Publicado: (2022)

Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model
por: Cheng, Xu, et al.
Publicado: (2023)

Biomarkers of Favorable vs. Unfavorable Responses in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy
por: Lee, Hsin-Hua, et al.
Publicado: (2022)

Whole-lesion ADC histogram and texture analysis in predicting recurrence of cervical cancer treated with CCRT
por: Meng, Jie, et al.
Publicado: (2017)

Time interval between the completion of radiotherapy and robotic-assisted surgery among patients with stage I–III rectal cancer undergoing preoperative chemoradiotherapy
por: Huang, Ching-Wen, et al.
Publicado: (2020)

Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression
por: Li, Guangchao, et al.
Publicado: (2014)

Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: Which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study
por: Lim, Kyu-Hyoung, et al.
Publicado: (2009)

Serum miRNAs, a potential prognosis marker of loco-regionally advanced nasopharyngeal carcinoma patients treated with CCRT
por: Zhang, Zhimin, et al.
Publicado: (2020)

MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition
por: David, Justin M., et al.
Publicado: (2016)

Predicting Disease-Free Survival With Multiparametric MRI-Derived Radiomic Signature in Cervical Cancer Patients Underwent CCRT
por: Liu, Bing, et al.
Publicado: (2022)

Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder
por: He, Hong-Lin, et al.
Publicado: (2023)

NACT+IMRT versus NACT+IMRT+CCRT in locoregionally advanced NPC patients: a retrospective study
por: Chen, Xialin, et al.
Publicado: (2019)

Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancer
por: Lim, Sung Hee, et al.
Publicado: (2021)

PLCB4 upregulation is associated with unfavorable prognosis in pediatric acute myeloid leukemia
por: Wu, Shiwen, et al.
Publicado: (2019)

Helical Tomotherapy Combined with Capecitabine in the Preoperative Treatment of Locally Advanced Rectal Cancer
por: Huang, Ming-Yii, et al.
Publicado: (2014)

Elevated Preoperative NMPR Predicts an Unfavorable Chance of Survival in Resectable Esophageal Squamous Cell Carcinoma
por: Peng, Meng-Ying, et al.
Publicado: (2022)

Durvalumab as Consolidation Therapy in Post-Concurrent Chemoradiation (CCRT) in Unresectable Stage III Non-Small Cell Lung Cancer Patients: A Multicenter Observational Study
por: Wang, Chin-Chou, et al.
Publicado: (2021)

Upregulation of PODXL and ITGB1 in pancreatic cancer tissues preoperatively obtained by EUS-FNAB correlates with unfavorable prognosis of postoperative pancreatic cancer patients
por: Taniuchi, Keisuke, et al.
Publicado: (2022)

Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer
por: Huang, Ming-Yii, et al.
Publicado: (2018)

PCSK1 Overexpression in Rectal Cancer Correlates with Poor Response to Preoperative Chemoradiotherapy and Prognosis
por: Chou, Chia-Lin, et al.
Publicado: (2020)

DCE-MRI Quantitative Parameters as Predictors of Treatment Response in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Underwent CCRT
por: Liu, Bing, et al.
Publicado: (2020)

Upregulated MMP28 in Hepatocellular Carcinoma Promotes Metastasis via Notch3 Signaling and Predicts Unfavorable Prognosis
por: Zhou, Jiangfan, et al.
Publicado: (2019)

CCRT and aerobic exercise: a randomised controlled study of processing speed, cognitive flexibility, and serum BDNF expression in schizophrenia
por: Dai, Yuanyuan, et al.
Publicado: (2022)

MUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner
por: Jin, Wei, et al.
Publicado: (2017)

Angiogenin Upregulation Independently Predicts Unfavorable Overall Survival in Proneural Subtype of Glioblastoma
por: Hu, Ji-liang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9updgpl4bhfh3smvlq3musf1e0